The Latest Breaking News from Vaccine

Moderna’s (MRNA) mRNA platform is positioned to deliver significant long-term impact with its mRNA medicines, but declining sales amid plummeting demand for its COVID-19 vaccine, steep losses, and cash burn reflect uncertainty around its near-term prospects. As MRNA is set to release its fourth-quarter 2023 results this Thursday, let’s find…

The researchers cautioned that the study found only associations with adverse health effects and it does not prove that these issues are caused by the vaccines.

Ebola is one of the most feared infectious diseases, with more than half of those infected dying. A vaccine has now been shown to cut that mortality rate in half.

Health officials warn clusters are appearing outside West Midlands.

This spring those at the highest risk will miss out on the jab. Meanwhile, the government will be throwing away vaccines, says immunologist Sheena Cruickshank

Various forms of cancer continue to claim millions of lives globally every year.

Russian President Vladimir Putin announces that Russian scientists are close to developing cancer vaccines, with hopes of effective individual therapy.

GSK's stock has been a poor performer for years. But recently, the pharma stock keeps setting new 52-week highs, thanks to its blockbuster vaccines.

Dr Durrheim says the whooping cough vaccine is life saving.